Indicator | Operational definition |
Indicators related to BP screening and hypertension diagnosis | |
Adequate availability of the Healthy Hearts service | Number of effective opening hours of the Healthy Hearts service in a week/Number of programmed opening hours of the Healthy Hearts service per week |
Effective referral to the Healthy Hearts service and BP screening | Number of people without BP measurement in the last year and referred for BP measurement that reaches and receive BP screening at the Healthy Hearts service/Total number of people without BP measurement in the previous year referred for BP measurement to the Healthy Hearts service |
Referral for serial BP measurement to the Healthy Hearts service | Number of patients not previously enrolled in the CVRP with high BP detected at the doctor or nurse consultation who are referred for serial BP measurement to the Healthy Hearts service during the reporting month/Total number of patients not previously enrolled in the CVRP with high BP detected at the doctors or nurses consultation during the reporting month |
Implementation of serial BP measurements at Healthy Hearts service | Number of individuals with high BP detected by BP screening at the Healthy Hearts service who receive serial (≥3) BP measurements/Total number of individuals with high BP detected by BP screening at the Healthy Hearts service |
Result of serial BP measurement | Number of patients with average systolic BP≥140 mm Hg or diastolic BP≥90 mm Hg at serial (≥3) BP measurement/Number of individuals receiving serial BP measurements |
Implementation of serial self-measured BP monitoring | Number of patients with serial self-measured BP monitoring/Number of patients with indication of serial self-measured BP monitoring |
Result of serial self-measured BP monitoring | Number of patients with average systolic BP≥140 mm Hg or diastolic BP≥90 mm Hg as a result of a serial self-measured BP monitoring/Number of patients with serial self-measured BP monitoring |
Indicators related to the hypertension management programme | |
Implementation of BP measurements by medical and nursing staff | Number of interviewed individuals referring that they had a BP measurement/Total number of exit-interviews |
Missed hypertension-related appointment | Number of patients who missed their last hypertension-related appointment during the reporting week/Patients with scheduled hypertension follow-up visits during the reporting week |
Correct prescription of pharmacological treatment | Number of patients who received a proper prescription of pharmacological treatment according to the clinical condition and defined algorithm/Total number of audited clinical records |
Use of recommended antihypertensive drugs | Number of patients who received a prescription of antihypertensive drugs included in the standardised algorithm/Total number of hypertensive patients receiving pharmacological treatment in the audited clinical records |
Pharmacological advice by the medical doctor during the consultation | Number of interviewed hypertensive patients who referred they received pharmacological advice by the medical doctor/Total number of exit interviews |
Percentage of hypertensive patients who received prescription of non-pharmacological treatment | Number of interviewed who refer they received a prescription of non-pharmacological treatment by the doctor/Total number of exit interviews |
Indicators related to the training of healthcare staff | |
Trained healthcare professionals | Number of trained professionals |
Effectiveness of training in improving clinical knowledge | Average post-test score minus average pretest score |
Effectiveness of training on acquiring BP measurement skills | Number of trained professionals passing the post-training practical test/Total number of trained professionals |
Indicators related to stock management and availability of the essential antihypertensive medication | |
Number of weeks without availability of essential antihypertensive drugs | Number of weeks without availability of one or more essential antihypertensive drugs |
Indicators related to patients and community engagement | |
Attendance to peer support group | Number of hypertensive patients who participate in the meetings of the peer support group/Number of hypertensive patients enrolled in the CVRP eligible for peer support and referred |
BP screening in the population by the Community Hypertension Outreach Group (CHOG) | Number of people screened and prevalence of high BP readings during the screening |
Participation of community leaders in the meetings of the CHOG | Number of community leaders participating in the meetings of the CHOG/Total number of community leaders in the CHOG |
BP, blood pressure; CVRP, Cardiovascular Risk Programme.